DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Esaxerenone
Esaxerenone
Download
Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic Paradigm
Ovid MEDLINE(R)
Mineralocorticoid Receptor Blockers for Moderate Kidney Dysfunction: More Merit Than Ever?
The Role of Aldosterone Inhibitors on Cardiac Ischemia/Reperfusion Injury
Stembook 2018.Pdf
Report on the Deliberation Results December 4, 2018 Pharmaceutical
Esaxerenone: First Global Approval
Characterization of Direct Perturbations on Voltage-Gated Sodium Current by Esaxerenone, a Nonsteroidal Mineralocorticoid Receptor Blocker
Daiichi Sankyo Group Value Report 2017
The 2020 Italian Society of Arterial Hypertension (SIIA) Practical Guidelines for the Management of Primary Aldosteronism
Diabetics Could Boost Daiichi's Nascent Heart Asset
Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
The Role of Spironolactone in Patients With
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Drug–Drug Interaction Risk Assessment of Esaxerenone As a Perpetrator by in Vitro Studies and Static and Physiologically Based Pharmacokinetic Models
FDA-Approved Drug Library Mini (96-Well)
Identification Et Régulation Transcriptionnelle Des Gènes
Top View
Esaxerenone, a Novel Mineralocorticoid Receptor Blocker
Mineralocorticoid Receptor
Finerenone — Halting Relative Hyperaldosteronism in Chronic Kidney Disease
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Universidade De Brasília Faculdade De Ciências Da Saúde
(CS-3150) for the Treatment of Essential Hypertension: a Phase 2 Randomized, Placebo-Controlled, Double-Blind Study
Eplerenone Versus Spironolactone in Resistant Hypertension: an Efficacy And/Or Cost Or Just a Men’Sissue?
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
Drug Repurposing Compound Library (96-Well)
Characterization of Pendrin in Urinary Extracellular Vesicles in a Rat Model of Aldosterone Excess and in Human Primary Aldosteronism
Pharmacokinetics, Metabolism, and Excretion of [14C]Esaxerenone, a Novel Mineralocorticoid Receptor Blocker in Humans S
Synergistic Reduction in Albuminuria in Type 2 Diabetic Mice by Esaxerenone
Efficacy and Safety of Esaxerenone (CS-3150), a Newly Available
Touchendocrinology Touch
Mineralocorticoid Receptor Antagonists: Achieving Cardiovascular Benefit with Minimized Renal Side Effects? European Heart Journal 34 2426–2428
Long-Term Phase 3 Study of Esaxerenone As Mono Or Combination Therapy with Other Antihypertensive Drugs in Patients with Essential Hypertension